Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
⚗️ Ingredient
Bismuth
8
Clinical Trials
11
Meta-Analyses
0
PubMed References
Top Conditions Studied with Bismuth
Helicobacter Pylori Infection 2
Helicobacter pylori, high dose dual therapy, eradication rat 1
Gastritis|Dyspepsia|Helicobacter Pylori Infection|Gastric Ca 1
Helicobacter pylori infection. First-line treatment for adul 1
Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Ca 1
Helicobacter pylori infection; concomitant therapy; triple t 1
Helicobacter pylori infection has been proved to be the majo 1
Helicobacter pylori (H.pylori) infection is a common global 1
Asia has the largest population of any continent and the hig 1
The Cochrane Upper GI and Pancreatic Diseases Group 1
the Eradication Rates of Helicobacter Pylori 1
Microscopic colitis (i.e. lymphocytic- and collagenous colit 1
📋 Sample Trials
NCT05664685
Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication
Completed · Phase 4
NCT05930197
Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults
Recruiting · Phase 1
NCT05997433
Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori（SHARE2302)
Recruiting
📊 Sample Meta-Analyses
CRD42016032668
Non-bismuth concomitant quadruple therapy for Helicobacter pylori eradication in the Chinese region: a meta-analysis of randomized controlled trials
Helicobacter pylori infection has been proved to be the major cause of chronic g
CRD42017081328
Non-bismuth quadruple therapy versus triple therapy in patients with naïve Helicobacter pylori infection
Helicobacter pylori infection; concomitant therapy; triple therapy; antibiotic r
CRD42017083215
Antacids, sucralfate and bismuth salts for functional dyspepsia [Cochrane protocol]
The Cochrane Upper GI and Pancreatic Diseases Group
📚 Sample References
None linked yet.
⚗️ All Ingredient data fields for Bismuth
⚗️ Identity
Name
Bismuth
Aliases / Synonyms
7440-69-9; Bi; bismuth atom; Bismuth, elemental;; Bismuth - Bi @ 1000 microg/g in Hydrocarbon Oil; Bismuth AA Standard: Bi @ 1000 microg/mL in 5% HNO3; bismuto; Bismuth Internal Standard: Bi @ 0.793 g/L in Mineral Oil; Bismuth Standard: Bi @ 1000 microg/mL in 5% HNO3
🧪 Chemistry
Molecular Weight
208.9800
LogP
-0.3808
Drug-likeness
0.477
🔬 Structures
Canonical SMILES
[Bi]
Isomeric SMILES
[Bi]
InChIKey
JCXGWMGPZLAOME-UHFFFAOYSA-N
InChI
InChI=1S/Bi
🔗 External References
🔍 Raw view — every non-empty column on this row (27 fields)
name
Bismuth
common names
7440-69-9; Bi; bismuth atom; Bismuth, elemental;; Bismuth - Bi @ 1000 microg/g in Hydrocarbon Oil; Bismuth AA Standard: Bi @ 1000 microg/mL in 5% HNO3; bismuto; Bismuth Internal Standard: Bi @ 0.793 g/L in Mineral Oil; Bismuth Standard: Bi @ 1000 microg/mL in 5% HNO3
herb ingredient id
HBIN018632
canonical smiles
[Bi]
isomeric smiles
[Bi]
inchi
InChI=1S/Bi
inchikey
JCXGWMGPZLAOME-UHFFFAOYSA-N
mol wt
208.9800
num h acceptors
0
num h donors
0
mol logp
-0.3808
num rotatable bonds
0
drug likeness
0.477
tcmid ingredient id
32763
pubchem cid
5359367
📋 Clinical Trials
8 · subject of clinical studyNCT05664685 Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter
→ Helicobacter Pylori Infection
NCT05930197 Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healt
→ Healthy Adults
NCT05997433 Efficacy of 7-day Versus 14-day Bismuth Quadruple Therapy for the Eradication of
→ Helicobacter Pylori Infection
NCT05915871 Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromyc
→ Healthy
NCT05742568 Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter
→ Gastritis|Dyspepsia|Helicobacter Pylori Infection|
NCT06168084 Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus B
→ Gastritis Dyspepsia Helicobacter Pylori Infection
NCT06168214 Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual
→ the Eradication Rates of Helicobacter Pylori
NCT05850117 Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxa
→ Helicobacter Pylori Eradication
📊 Meta-Analyses
11 · systematic reviewCRD42016032668 Non-bismuth concomitant quadruple therapy for Helicobacter pylori eradication in
→ Helicobacter pylori infection has been proved to b
CRD42017081328 Non-bismuth quadruple therapy versus triple therapy in patients with naïve Helic
→ Helicobacter pylori infection; concomitant therapy
CRD42017083215 Antacids, sucralfate and bismuth salts for functional dyspepsia [Cochrane protoc
→ The Cochrane Upper GI and Pancreatic Diseases Grou
CRD42019129064 Eradication efficacy of modified dual therapy compared with bismuth-containing q
→ Helicobacter pylori, high dose dual therapy, eradi
CRD42020159192 Comparison of high-dose dual therapy，bismuth-based quadruple therapy and
→ Helicobacter pylori infection. First-line treatmen
CRD42020201227 Bismuth, zirconium, tungsten, and tantalum ions systemic accumulation in humans:
→ Hydraulic calcium silicate-based reparative cement
CRD42020218649 Clinical response of biologics, immunomodulators and bismuth subsalicylate in mi
→ Microscopic colitis (i.e. lymphocytic- and collage
CRD42021270323 Bismuth effect in human kidneys: a systematic review
→ Hydraulic calcium silicate-based reparative cement
CRD42022295372 Systematic Review and Meta-analysis of 10 and 14 days Bismuth-containing Quadrup
→ Helicobacter pylori (H.pylori) infection is a comm
CRD42022313256 Efficacy of bismuth for improving the eradication rate of clarithromycin/metroni
→ Helicobacter pylori; eradiction rate of antibiotic
CRD42022332462 Efficacy of adding bismuth to primary Helicobacter pylori eradication therapy :
→ Asia has the largest population of any continent a
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
ACTIVE — direct link via
herb_ingredients - Ingredient ↔ Target:
ACTIVE — direct link via
ingredient_targets - Target ↔ Disease:
ACTIVE — direct link via
target_health_topics - Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables